Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Caprilli

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 12, 2002
Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide studyA Viscido, V Bagnardi, G C Sturniolo, et al.
International Journal of Colorectal Disease|August 2, 2005
Two synchronous adenocarcinomas of the small bowel in a patient with undiagnosed Crohn's disease of the terminal ileumP Sammartino, S Sibio, A Di Giorgio, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2003
Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trialR Caprilli, M Cottone, F Tonelli, et al.
Alimentary Pharmacology & Therapeutics|May 8, 1999
Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine. Gruppo Italiano per lo Studio del Colon e del RettoG Frieri, M T Pimpo, A Andreoli, et al.
Clinical and Experimental Immunology|April 7, 1998
Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD)R Giacomelli, A Passacantando, I Parzanese, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2007
The association of MYO9B gene in Italian patients with inflammatory bowel diseasesA Latiano, O Palmieri, M R Valvano, et al.
European Journal of Clinical Investigation|March 19, 2003
Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trialP Vernia, V Annese, G Bresci, et al.
The American Journal of Gastroenterology|July 14, 2000
Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del RettoG Frieri, M T Pimpo, G Palumbo, et al.
Alimentary Pharmacology & Therapeutics|August 15, 2009
Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with AsacolC Prantera, A Kohn, M Campieri, et al.
Italian Journal of Gastroenterology and Hepatology|June 1, 1997
Appendectomy is an independent protective factor for ulcerative colitis: results of a multicentre case control study. The Italian Group for the Study of the Colon and Rectum (GISC)T Parrello, M Pavia, I F Angelillo, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 12, 2002
Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide studyA Viscido, V Bagnardi, G C Sturniolo, et al.
International Journal of Colorectal Disease|August 2, 2005
Two synchronous adenocarcinomas of the small bowel in a patient with undiagnosed Crohn's disease of the terminal ileumP Sammartino, S Sibio, A Di Giorgio, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2003
Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trialR Caprilli, M Cottone, F Tonelli, et al.
Alimentary Pharmacology & Therapeutics|May 8, 1999
Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine. Gruppo Italiano per lo Studio del Colon e del RettoG Frieri, M T Pimpo, A Andreoli, et al.
Clinical and Experimental Immunology|April 7, 1998
Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD)R Giacomelli, A Passacantando, I Parzanese, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2007
The association of MYO9B gene in Italian patients with inflammatory bowel diseasesA Latiano, O Palmieri, M R Valvano, et al.
European Journal of Clinical Investigation|March 19, 2003
Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trialP Vernia, V Annese, G Bresci, et al.
The American Journal of Gastroenterology|July 14, 2000
Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del RettoG Frieri, M T Pimpo, G Palumbo, et al.
Alimentary Pharmacology & Therapeutics|August 15, 2009
Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with AsacolC Prantera, A Kohn, M Campieri, et al.
Italian Journal of Gastroenterology and Hepatology|June 1, 1997
Appendectomy is an independent protective factor for ulcerative colitis: results of a multicentre case control study. The Italian Group for the Study of the Colon and Rectum (GISC)T Parrello, M Pavia, I F Angelillo, et al.
Pageof 11